Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Treatment with glucocorticoids in COVID patients. Low-intervention, phase IV, open-label,
randomised, low-intervention clinical trial comparing 2 active treatments.
Phase:
Phase 4
Details
Lead Sponsor:
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León